Trending Now
Cannabis Stocks: Deep Value Opportunity as Legislative Factors Line Up? (CURLF,...
The legislative factor driving the cannabis space in the stock market shouldn’t be underappreciated by long-term investors and speculators alike. The movement...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Precision BioSciences (NASDAQ:DTIL) Enters Oncology Development Partnership With SpringWorks (NASDAQ:SWTX) And...
Precision BioSciences (NASDAQ:DTIL) has announced that it has entered a clinical trial partnership agreement with SpringWorks Therapeutics Inc. (NASDAQ:SWTX) to evaluate PBCAR269A in combination...
MAKE IT MODERN
LATEST REVIEWS
Kodiak Sciences Inc (KOD): A Promising Bet in the Biopharmaceutical Space...
In the bustling arena of biopharmaceutical advancements, Kodiak Sciences Inc. (NASDAQ:KOD) is emerging as a key player, particularly in the field of...
MAKE IT MODERN
PERFORMANCE TRAINING
Mangoceuticals Inc (MGRX) Leverages Podcast Popularity to Promote Men’s Wellness Product
Dallas, Texas, July 27, 2023 - In a major stride towards improving its market presence, Mangoceuticals Inc. (NASDAQ: MGRX), a leading brand...
Applied DNA Sciences Inc (APDN) could keep surging and here’s why
Shares of Applied DNA Sciences Inc (APDN) are currently trading at 2.7650 with a gain of over $0.7650 (+38.2500%). The stock is...
Akebia Therapeutics Inc. (NASDAQ:AKBA) Presents Positive INNO¬2VATE Phase 3 Clinical Vadadustat Data
Akebia Therapeutics Inc. (NASDAQ:AKBA) has announced the presentation go its INNO2VATE Phase 3 clinical study data at the 2020 Reimagined American Society of Nephrology...
Brickell Biotech Inc. (NASDAQ: BBI) Announces Q3 2021 Financial Results and Sofpironium Bromide gel,...
Brickell Biotech Inc. (NASDAQ: BBI) has announced Q3 2021 financial results and also offered a corporate update about its development programs.
Positive topline results were...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Announce Expanded Access Protocol For IOTs Mino-Lok Solution
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) has announced that it will offer healthcare providers free access to its Mino-Lok under an Expanded Access program as a...
MAKE IT MODERN
